Send to

Choose Destination
Clin Adv Hematol Oncol. 2015 Mar;13(3):186-93.

Review of treatment options for oligometastatic non-small cell lung cancer.

Author information

University of Texas Southwest Medical Center, Dallas, Texas.


Our understanding of metastatic disease is constantly evolving. Although outcomes for patients with stage IV non-small cell lung cancer (NSCLC) are poor, aggressive/radical local intervention may be effective in a subset of patients with limited or "oligometastatic" disease. Here we review and compare the range of available treatment options that are specific to oligometastatic NSCLC, and discuss potential directions of future clinical research.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center